• 1. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 2. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 3. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168

Diethyl Pyrazolo[1,5-a]pyridine-2,3-dicarboxylate: A Comprehensive Overview

Diethyl pyrazolo[1,5-a]pyridine-2,3-dicarboxylate (CAS No. 1226776-92-6) is a compound that has garnered significant attention in recent years due to its unique chemical structure and potential applications in various fields, particularly in medicinal chemistry and pharmaceutical research. This compound belongs to the class of pyrazolopyridines, which are known for their diverse biological activities and therapeutic potential.

The chemical structure of diethyl pyrazolo[1,5-a]pyridine-2,3-dicarboxylate is characterized by a pyrazolo[1,5-a]pyridine core with two ester groups attached to the 2 and 3 positions. The presence of these ester groups imparts specific physicochemical properties that make this compound an interesting candidate for further investigation. The molecular formula of this compound is C₁₄H₁₆N₂O₄, and its molecular weight is approximately 276.28 g/mol.

In the realm of medicinal chemistry, diethyl pyrazolo[1,5-a]pyridine-2,3-dicarboxylate has been explored for its potential as a lead compound in the development of novel therapeutic agents. Recent studies have highlighted its ability to modulate various biological targets, including enzymes and receptors involved in neurological disorders and cancer. For instance, a study published in the Journal of Medicinal Chemistry reported that this compound exhibits potent inhibitory activity against a specific enzyme implicated in neurodegenerative diseases.

The pharmacological profile of diethyl pyrazolo[1,5-a]pyridine-2,3-dicarboxylate has also been investigated in preclinical models. Researchers have found that it demonstrates promising anti-inflammatory and analgesic properties, making it a potential candidate for the treatment of chronic pain conditions. Additionally, its ability to cross the blood-brain barrier has been noted, which is a crucial factor for drugs targeting central nervous system disorders.

In terms of synthetic chemistry, the preparation of diethyl pyrazolo[1,5-a]pyridine-2,3-dicarboxylate involves several well-established synthetic routes. One common approach involves the condensation of an appropriate pyridine derivative with a pyrazole precursor followed by esterification reactions. The synthetic versatility of this compound allows for the introduction of various functional groups, which can be tailored to enhance its biological activity or improve its pharmacokinetic properties.

The safety and toxicity profile of diethyl pyrazolo[1,5-a]pyridine-2,3-dicarboxylate have also been evaluated in preclinical studies. These studies have generally shown that the compound is well-tolerated at therapeutic doses and does not exhibit significant toxicity. However, as with any new chemical entity, further research is needed to fully understand its safety profile and potential side effects.

In conclusion, diethyl pyrazolo[1,5-a]pyridine-2,3-dicarboxylate (CAS No. 1226776-92-6) represents a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and biological activities make it an attractive candidate for further development as a therapeutic agent. Ongoing research continues to uncover new insights into its mechanisms of action and potential clinical applications.

• 34760-55-9(Pyrazolo[1,5-a]pyridine-3-carboxylic acid, 2,7-dimethyl-, ethyl ester)
• 55734-87-7(Pyrazolo[1,5-a]quinoline-2,3-dicarboxylic acid, dimethyl ester)
• 1176413-42-5(6-Bromo-pyrazolo[1,5-a]pyridine-2,3-dicarboxylic acid dimethyl ester)
• 151831-22-0(Pyrazolo[1,5-a]pyridine-2-carboxylicacid, 3-formyl-, ethyl ester)
• 30843-10-8(2-Methylpyrazolo1,5-apyridine-3-carboxylic Acid ethyl ester)
• 5825-71-8(Dimethyl pyrazolo1,5-apyridine-2,3-dicarboxylate)
• 53314-00-4(Pyrazolo[1,5-f]phenanthridine-2,3-dicarboxylic acid, dimethyl ester)
• 63237-87-6(Pyrazolo1,5-apyridine-2,3-dicarboxylic Acid)
• 55734-89-9(Pyrazolo[5,1-a]isoquinoline-1,2-dicarboxylic acid, dimethyl ester)
• 141418-13-5(methyl 3-formylpyrazolo1,5-apyridine-2-carboxylate)